MammaPrint®

When breast cancer is diagnosed, a surgeon will try to remove all breast cancer tumour cells from the body. However, some breast cancers can still recur months or years later. MammaPrint®, a product of Agendia, is a test used to determine how likely a tumour is to return.

The test is perfomed on a small sample of the tumour tissue and looks at the gene activity of the cancer tissue. This information is used to determine the behaviour of the tumour and provides a clear answer of low or high risk of recurrence within the next 10 years. This result will help your doctor determine the best treatment plan for you.

MammaPrint® can be used in cases when a breast cancer is diagnosed early and a result is available 10 working days after sample receipt.

Opaldia would be happy to discuss the MammaPrint® test with your doctor. For more information, please contact an Opaldia team member on 020 7554 4052.